Insider · CIK 0001237564

PAUL STEVEN M

Reports to the SEC for 8 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001237564

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-22	RAPPRapport Therapeutics, Inc.P Purchase	Director	PPurchase	+35.7K sh	$27.28	+$974K	77,380
2026-06-10	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.2K sh	—	—	15,200
2026-05-04	SPTXSeaport Therapeutics, Inc.C Conversion	Director	CConversion	+67K sh	—	—	863,031
2026-05-04	SPTXSeaport Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−211K sh	—	—	0
2026-04-30	SPTXSeaport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.3K sh	—	—	12,258
2026-04-30	SPTXSeaport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+991K sh	—	—	991,192
2025-09-12	RAPPRapport Therapeutics, Inc.P Purchase	Director	PPurchase	+28.3K sh	$24.50	+$693K	28,284
2025-09-12	RAPPRapport Therapeutics, Inc.P Purchase	Director	PPurchase	+13.4K sh	$24.97	+$334K	41,666
2025-06-17	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.9K sh	—	—	21,850
2024-03-18	Karuna Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−2,046 sh	$330.00	−$675K	8,550
2024-03-18	Karuna Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−8,550 sh	$330.00	−$2.82M	0
2024-03-18	Karuna Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−30.3K sh	$330.00	−$10M	0
2024-03-18	Karuna Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	$330.00	−$3.3M	0
2024-03-18	Karuna Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−33.9K sh	$330.00	−$11.2M	0
2024-03-18	Karuna Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−30.3K sh	$330.00	−$10M	0
2024-03-18	Karuna Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−35.9K sh	$330.00	−$11.8M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−136K sh	$322.96	−$44M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−757K sh	$322.73	−$244M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−449K sh	$320.80	−$144M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−87.5K sh	$320.80	−$28.1M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.2K sh	$320.80	−$4.88M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−617K sh	$314.00	−$194M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−71.1K sh	$309.98	−$22M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−136K sh	$230.28	−$31.3M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−162K sh	$198.36	−$32.1M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−147K sh	$218.03	−$32M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22.8K sh	$142.74	−$3.25M	0
2024-03-04	Karuna Therapeutics, Inc.G Gift	Director	GGift	−30.3K sh	—	—	2,364
2024-03-04	Karuna Therapeutics, Inc.G Gift	Director	GGift	+30.3K sh	—	—	30,304
2024-03-01	Karuna Therapeutics, Inc.G Gift	Director	GGift	−30.3K sh	—	—	40,304
2024-03-01	Karuna Therapeutics, Inc.G Gift	Director	GGift	+30.3K sh	—	—	30,304
2024-03-01	Karuna Therapeutics, Inc.G Gift	Director	GGift	−30.3K sh	—	—	10,000
2024-03-01	Karuna Therapeutics, Inc.G Gift	Director	GGift	+30.3K sh	—	—	32,668
2024-02-29	Karuna Therapeutics, Inc.J Other	Director	JOther	+47.4K sh	$315.18	+$14.9M	70,608
2024-02-23	Karuna Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+27.5K sh	$7.27	+$200K	38,106
2024-02-23	Karuna Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,008 sh	$99.72	+$400K	42,114
2024-02-23	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−27.5K sh	—	—	757,045
2024-02-23	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,008 sh	—	—	135,992
2024-02-09	Karuna Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−804 sh	$317.14	−$255K	10,596
2024-01-03	Sage Therapeutics, Inc.Stock Options (Right to buy)A Award	Director	AAward	+3,971 sh	—	—	3,971
2023-06-15	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-02-09	Karuna Therapeutics, Inc.A Award	Director	AAward	+11.4K sh	—	—	11,400
2023-02-09	Karuna Therapeutics, Inc.Option (Right to Buy)A Award	Director	AAward	+22.8K sh	—	—	22,800
2023-01-04	Sage Therapeutics, Inc.Stock Options (Right to buy)A Award	Director	AAward	+2,395 sh	—	—	2,395
2022-11-28	Sage Therapeutics, Inc.J Other	Director	JOther	+5 sh	$38.17	+$190.837	78,539
2022-06-16	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+9,947 sh	—	—	9,947
2022-05-31	Karuna Therapeutics, Inc.G Gift	Director	GGift	−106K sh	—	—	0
2022-05-31	Karuna Therapeutics, Inc.G Gift	Director	GGift	+106K sh	—	—	106,485
2022-05-27	Karuna Therapeutics, Inc.G Gift	Director	GGift	−106K sh	—	—	0
2022-05-27	Karuna Therapeutics, Inc.G Gift	Director	GGift	+106K sh	—	—	106,485

Recent filings

Accepted (ET)
Oct 224
PAUL STEVEN M0001193125-26-429073
SEC(opens sec.gov)
Jun 104
PAUL STEVEN M0001193125-26-266129
SEC(opens sec.gov)
May 44
PAUL STEVEN M0001193125-26-204465
SEC(opens sec.gov)
Sep 154
PAUL STEVEN M0001193125-25-203537
SEC(opens sec.gov)
Jun 184
PAUL STEVEN M0000950170-25-087898
SEC(opens sec.gov)
Mar 184
PAUL STEVEN M0001140361-24-013933
SEC(opens sec.gov)

Companies

Address

RAPPORT THERAPEUTICS, INC. 99 HIGH STREET, SUITE 2100

BOSTON, MA, 02110